trinitrotoluene has been researched along with Cancer of Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar, J; Dudnik, E; Gottfried, M; Maimon, N; Merimsky, O; Mishaeli, M; Moskovitz, M; Onn, A; Peled, N; Popovich-Hadari, N; Rosenberg, SK; Rotenberg, Y; Shamai, S; Urban, D; Wollner, M; Zer, A | 1 |
1 other study(ies) available for trinitrotoluene and Cancer of Lung
| Article | Year |
|---|---|
ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data.
Topics: Anaplastic Lymphoma Kinase; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Trinitrotoluene | 2022 |